This study aimed to evaluate the safety of Manhuning oral liquid and to provide safety basis for clinical treatment. A total of 120 chickens of 14 days old were selected. After one week of adaptive feeding, they were ...This study aimed to evaluate the safety of Manhuning oral liquid and to provide safety basis for clinical treatment. A total of 120 chickens of 14 days old were selected. After one week of adaptive feeding, they were evenly and randomly divided into four groups： one time the therapeutic dose （T1）, three times the therapeutic dose （T2）, five times the therapeutic dose （T3） and control （CK）. In different groups, the chickens were fed with Manhuning oral liquid according to the set doses for one week. At the beginning and at the end of the experiment, total 10 chickens were selected randomly from each group, respectively. They were weighed, and their blood was sampled for determination of routine blood indexes and examination of liver and kidney function. Organ indexes were determined, and pathological examination was conducted for the head, liver, spleen, lung and kidney of the chickens. The results showed that the body mass gain and organ indexes differed insignificantly among different groups （P〉0.05）. No significant differences were found in the routine blood indexes, serum ALT activity, albumin content, creatinine content and urea content among different groups before and after the experiment （P〉0.05）. After the administration, the head, liver, spleen, lung and kidney of the chickens showed no obvious abnormalities. In shod, Manhuning oral liquid had little impact on the physiological and biochemical indexes and had no toxic effects on the head, liver, spleen, lung and kidney of chickens, and it is a low-toxicity safe veterinary drug preparation.展开更多
文摘This study aimed to evaluate the safety of Manhuning oral liquid and to provide safety basis for clinical treatment. A total of 120 chickens of 14 days old were selected. After one week of adaptive feeding, they were evenly and randomly divided into four groups： one time the therapeutic dose （T1）, three times the therapeutic dose （T2）, five times the therapeutic dose （T3） and control （CK）. In different groups, the chickens were fed with Manhuning oral liquid according to the set doses for one week. At the beginning and at the end of the experiment, total 10 chickens were selected randomly from each group, respectively. They were weighed, and their blood was sampled for determination of routine blood indexes and examination of liver and kidney function. Organ indexes were determined, and pathological examination was conducted for the head, liver, spleen, lung and kidney of the chickens. The results showed that the body mass gain and organ indexes differed insignificantly among different groups （P〉0.05）. No significant differences were found in the routine blood indexes, serum ALT activity, albumin content, creatinine content and urea content among different groups before and after the experiment （P〉0.05）. After the administration, the head, liver, spleen, lung and kidney of the chickens showed no obvious abnormalities. In shod, Manhuning oral liquid had little impact on the physiological and biochemical indexes and had no toxic effects on the head, liver, spleen, lung and kidney of chickens, and it is a low-toxicity safe veterinary drug preparation.
